Insud Pharma Slu

General

Total Cases2
Active Cases1
Patents--
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
02/23/23
REDACTED VERSION of (17 in 1:22-cv-01196-CFC, 508 in 1:19-cv-00444-CFC-CJB) Letter by Arius Two, Inc., BioDelivery Sciences International, Inc.. (Attachments: # 1 Exs. 1-9)(Tigan, Jeremy) (Entered: 02/23/2023)
02/23/23
SO ORDERED, re (23 in 1:22-cv-01196-CFC, 515 in 1:19-cv-00444-CFC-CJB) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 24, 2023, filed by Insud Pharma S.L.U., IntelGenx Corp., IntelGenX Technologies Corp., Xiromed, LLC, Chemo Research, S.L., Insud Pharma S.L., IntelGenx Technologies Corp. Signed by Judge Colm F. Connolly on 2/23/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(kmd) (Entered: 02/23/2023)
02/22/23
STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 24, 2023 - filed by Chemo Research, S.L., Insud Pharma S.L.U., IntelGenx Corp., IntelGenx Technologies Corp., Xiromed, LLC, Insud Pharma S.L.. (Wilson, Samantha) (Entered: 02/22/2023)
02/17/23
STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 22, 2023 - filed by Arius Two, Inc., BioDelivery Sciences International, Inc.. (Tigan, Jeremy) (Entered: 02/17/2023)
02/17/23
SO ORDERED, re (22 in 1:22-cv-01196-CFC, 514 in 1:19-cv-00444-CFC-CJB) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 22, 2023 filed by BioDelivery Sciences International, Inc., Arius Two, Inc. Signed by Judge Colm F. Connolly on 2/17/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/17/2023)
02/15/23
SO ORDERED, re (513 in 1:19-cv-00444-CFC-CJB, 21 in 1:22-cv-01196-CFC) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC to February 17, 2023 filed by Insud Pharma S.L.U., IntelGenx Corp., IntelGenX Technologies Corp., Xiromed, LLC, Chemo Research, S.L., Insud Pharma S.L., IntelGenx Technologies Corp. Signed by Judge Colm F. Connolly on 2/15/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/15/2023)
02/14/23
STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC to February 17, 2023 - filed by Chemo Research, S.L., Insud Pharma S.L.U., IntelGenx Corp., IntelGenx Technologies Corp., Xiromed, LLC, Insud Pharma S.L.. (Wilson, Samantha) (Entered: 02/14/2023)
02/13/23
SO ORDERED, re (512 in 1:19-cv-00444-CFC-CJB, 20 in 1:22-cv-01196-CFC) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 14, 2023 filed by BioDelivery Sciences International, Inc., Arius Two, Inc. Signed by Judge Colm F. Connolly on 2/13/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(nmf) (Entered: 02/13/2023)
02/10/23
STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I. 508 in 19-444-CFC, D.I. 17 in 22-1196-CFC) to February 14, 2023 - filed by Arius Two, Inc., BioDelivery Sciences International, Inc.. (Tigan, Jeremy) (Entered: 02/10/2023)
02/09/23
SO ORDERED, re (510 in 1:19-cv-00444-CFC-CJB) (18 in 1:22-cv-01196-CFC) STIPULATION TO EXTEND TIME to file a redacted version of the Joint Status Report (D.I 508 in 1:19-cv-00444-CFC-CJB) (D.I. 17 in 1:22-cv-01196-CFC) filed by IntelGenx Corp., IntelGenX Technologies Corp., Chemo Research, S.L., Insud Pharma S.L., Xiromed, LLC. Signed by Judge Colm F. Connolly on 2/9/2023. Associated Cases: 1:19-cv-00444-CFC-CJB, 1:22-cv-01196-CFC(kmd) (Entered: 02/09/2023)